MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines

The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines

(2011) Ana Podolski-Renić et al.   BIOMEDICINE & PHARMACOTHERAPY

Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo

(2009) M. L.H. Vlaming et al.   CLINICAL CANCER RESEARCH

East African countries struggle with visceral leishmaniasis

(2009) Talha Burki   LANCET

Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate

(2008) M. L.H. Vlaming et al.   CLINICAL CANCER RESEARCH

Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

(2008) Jalid Sehouli et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer

(2008) Gabriella Ferrandina et al.   JOURNAL OF CLINICAL ONCOLOGY